Stockscreener 앱 받기
11.50
0.86%
-0.10
시간 외 거래:
11.50
전일 마감가:
$11.60
열려 있는:
$11.5
하루 거래량:
1,782
Relative Volume:
0.12
시가총액:
$92.29M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.21%
1개월 성능:
+9.73%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$11.50
$11.50
1주일 범위
$11.15
$12.63
52주 변동 폭
$10.00
$12.63
Jatt Ii Acquisition Corp Stock (JATT) Company Profile
명칭
Jatt Ii Acquisition Corp
전화
201-688-0364
주소
C/O APPLEBY GLOBAL SERVICES (CAYMAN) LTD, GEORGE TOWN
Compare JATT vs LION, XXI, UMAC, CCXI, DMII
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JATT
Jatt Ii Acquisition Corp
|
11.50 | 92.29M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
13.47 | 3.91B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.27 | 1.83B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
18.81 | 899.00M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
15.55 | 866.14M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.10 | 643.37M | 0 | 8.58M | -1.11M | 0.134 |
Jatt Ii Acquisition Corp 주식(JATT)의 최신 뉴스
Biotech-Focused Hedge Funds Back Talawar’s Fast Moving SPAC Merger - Institutional Investor
JATTJatt II Acquisition Corp Revenue Breakdown - Finviz
JATT II Acquisition (JATT) sponsor forfeits 225,000 shares after over-allotment expiry - Stock Titan
JATT II Acquisition Corp. (JATT) sponsor forfeits 225,000 Ordinary Shares - Stock Titan
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases - AOL.com
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger - Yahoo Finance
Price to book forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Talawar (NASDAQ: TLWR) to Merge with JATT II; $285M Expected - Stock Titan
Price to sales forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Talawar Therapeutics and JATT II Announce $285M Merger to Advance Bispecific Antibody for Atopic Dermatitis - Minichart
Talawar–JATT II deal includes $225M PIPE (NASDAQ: JATT) - Stock Titan
Talawar Tx launches as publicly traded biotech - The Pharma Letter
Enterprise value to revenue forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Enterprise value to EBIT forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
JATT II Acquisition to Merge With Talawar Tx; JATT to Become Subsidiary in SPAC Deal - TradingView
Talawar, JATT II (Nasdaq: JATT) unveil $225M PIPE-backed biotech merger - Stock Titan
Talawar Therapeutics To Go Public Through A SPAC Deal With JATT II Acquisition - Pulse 2.0
JATT II Acquisition, Talawar Therapeutics announce combination agreement - TipRanks
Press Release: Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases - Moomoo
Talawar Tx Inc. entered into a definitive business combination agreement to acquire JATT II Acquisition Corp. from JATT Ventures II L.P. in a reverse merger transaction. - marketscreener.com
JATT II ACQUISITION CORP (JATT) Stock Chart - ChartMill
OCAC.U Stock Fund Price and Chart — BOATS:OCAC.U - TradingView
JATT Price Today: JATT II Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC Exchange
BermudaAppleby Advises Amanat Acquisition In Its USD75M Initial Public Offering - Mondaq
JATT II Acquisition Corp 2026 Q1 SEC Filing: Financials, Management Discussion, and Regulatory Disclosures - Minichart
JATT II Acquisition Corp. 1Q 2026: Net income $(68,793), EPS $(0.05) — 10-Q Summary - TradingView
JATT II Acquisition Corp (NASDAQ: JATT) files 10-Q after $60M SPAC IPO - Stock Titan
Cayman IslandsAppleby Advises JATT II Acquisition Corp In Its USD60M Initial Public Offering - Mondaq
Oaktree’s OACC SPAC Looks Quiet. The October Deadline Is the Real Story - Bez Kabli
RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING - Yahoo Finance
JATT II Acquisition (JATT) Stock Analysis Report | Financials & Insights - Benzinga
JATT II Acquisition Corp (JATT) Price To Free Cash Flow - Zacks Investment Research
GUACU|Berto Acquisition II Units (Proposed)|Price:10.065|Chg%:0.04 - TradingKey
JATT Acquisition (JATT) Stock Price, News & Analysis $JATT - MarketBeat
JATT Technical Analysis & Stock Price Forecast - Intellectia AI
Number of shareholders of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
JATT II Acquisition Corp (JATT) Price To Cash Flow - Zacks Investment Research
OTAI_u|OTAI_u.NB|Price:10.074|Chg%:0.02 - TradingKey
BWIV|Blue Water Acquisition IV Redeemable Units|Price:9.905|Chg%:-0.02 - TradingKey
SAGU_u|SAGU_u.NB|Price:10.080|Chg%:-0.03 - TradingKey
JATT Stock Price, Quote & Chart | JATT II ACQUISITION CORP (NASDAQ:JATT) - ChartMill
JATT|JATT II Acquisition Ord Shs|Price:10.520|Chg%:0.02 - TradingKey
WENC_u|West Enclave Merger Units (Proposed)|Price:10.090|Chg%:0.09 - TradingKey
GLND Stock Price and Chart — NASDAQ:GLND - TradingView
RA Capital-backed holders report 500,000 shares in JATT II (JATT) - Stock Titan
JATT SEC FilingsJatt Ii Acquisition Corp 10-K, 10-Q, 8-K Forms - Stock Titan
JATT II Acquisition Corp 2026 Balance Sheet and Financial Statement Overview - Minichart
JATT II Acquisition completes $63M IPO and private placement, places $60M in trust - TradingView
JATT II Acquisition (Nasdaq: JATT) closes $60,000,000 IPO and funds trust - Stock Titan
Commodore reports 500,000-share (6.4%) stake in JATT II (NASDAQ: JATT) - Stock Titan
Great Point, Dr. Jay & Nordahl report 6.41% stake in JATT (NYSE: JATT) - Stock Titan
Jatt Ii Acquisition Corp (JATT) 재무 분석
Jatt Ii Acquisition Corp (JATT)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.00%
0.65%
자본화:
|
볼륨(24시간):